[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Böhmová et al., 2020 - Google Patents

Polymer cancerostatics containing cell-penetrating peptides: internalization efficacy depends on peptide type and spacer length

Böhmová et al., 2020

View HTML
Document ID
9362252547605104117
Author
Böhmová E
Pola R
Pechar M
Parnica J
Machová D
Janoušková O
Etrych T
Publication year
Publication venue
Pharmaceutics

External Links

Snippet

Cell-penetrating peptides (CPPs) are commonly used substances enhancing the cellular uptake of various cargoes that do not easily cross the cellular membrane. CPPs can be either covalently bound directly to the cargo or they can be attached to a transporting system …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Li et al. Click chemistry in peptide-based drug design
Böhmová et al. Polymer cancerostatics containing cell-penetrating peptides: internalization efficacy depends on peptide type and spacer length
Ptaszyńska et al. Conjugates of ciprofloxacin and levofloxacin with cell-penetrating peptide exhibit antifungal activity and mammalian cytotoxicity
Ali et al. Furan-conjugated tripeptides as potent antitumor drugs
Hymel et al. How cargo identity alters the uptake of cell-penetrating peptide (CPP)/Cargo complexes: A study on the effect of net cargo charge and length
El-Sayed et al. Design, synthesis, and evaluation of homochiral peptides containing arginine and histidine as molecular transporters
Gayraud et al. Recent Advances and Trends in Chemical CPP–Drug Conjugation Techniques
Del Genio et al. Design and validation of nanofibers made of self-assembled peptides to become multifunctional stimuli-sensitive nanovectors of anticancer drug doxorubicin
Salehi et al. Amphiphilic cell-penetrating peptides containing natural and unnatural amino acids as drug delivery agents
Park et al. EDB-FN Targeted Peptide–Drug Conjugates for Use against Prostate Cancer
Petrov et al. Polypeptide-based molecular platform and its docetaxel/sulfo-Cy5-containing conjugate for targeted delivery to prostate specific membrane antigen
Brunetti et al. A new NT4 peptide-based drug delivery system for cancer treatment
Parker et al. Design of silk-elastin-like protein nanoparticle systems with mucoadhesive properties
Takakura et al. In vitro and in vivo cell uptake of a cell-penetrating peptide conjugated with fluorescent dyes having different chemical properties
Pola et al. Targeted polymer-based probes for fluorescence guided visualization and potential surgery of EGFR-positive head-and-neck tumors
Cho et al. A tumor-homing peptide platform enhances drug solubility, improves blood–brain barrier permeability and targets glioblastoma
Rajendrakumar et al. Self-assembled, adjuvant/antigen-based nanovaccine mediates anti-tumor immune response against melanoma tumor
Ouyang et al. Recent advances of studies on cell-penetrating peptides based on molecular dynamics simulations
Hingorani et al. Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs
Yousef et al. Cell-penetrating dabcyl-containing tetraarginines with backbone aromatics as uptake enhancers
Pethő et al. Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates
Rosa et al. Peptide-based hydrogels and nanogels containing Gd (III) complexes as T1 relaxation agents
Narayanan et al. Poly-lysine dendritic nanocarrier to target epidermal growth factor receptor overexpressed breast cancer for methotrexate delivery
Illa et al. Chiral cyclobutane-containing cell-penetrating peptides as selective vectors for anti-Leishmania drug delivery systems
Zoghebi et al. [(WR) 8WKβA]-Doxorubicin conjugate: a delivery system to overcome multi-drug resistance against doxorubicin